Placental dysfunction in obese women and antenatal surveillance strategies

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 29, Issue 3, 2015, Pages 350-364

  Jeve, Yadava B ^a   Konje, Justin C ^a   Doshani, Anjum ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Antenatal; Obesity; Placental dysfunction

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT;

ARTICLE; BIRTH WEIGHT; CHILDHOOD OBESITY; FEMALE; FETUS GROWTH; HUMAN; HYPERINSULINEMIA; MATERNAL OBESITY; PATIENT COUNSELING; PLACENTA DISORDER; PREGNANCY DIABETES MELLITUS; PRENATAL PERIOD; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; DIABETES, GESTATIONAL; FETUS DEVELOPMENT; HIGH RISK PREGNANCY; INFLAMMATION; OBESITY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL CARE; WEIGHT GAIN;

DIABETES, GESTATIONAL; FEMALE; FETAL DEVELOPMENT; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; METFORMIN; OBESITY; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, HIGH-RISK; PRENATAL CARE; WEIGHT GAIN;

EID: 84933523788     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2014.09.007     Document Type: Article

References (114)

1. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev 2007 29 1-5.
2. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in bodyemass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 countryeyears and 9.1 million participants. The Lancet 2011 377 9765 557-67.
3. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998 22 12 1164-71.
4. Morgan KL, Rahman MA, Macey S, et al. Obesity in pregnancy: a retrospective prevalenceebased study on health service utilisation and costs on the NHS. BMJ Open 2014;4(2):e003983.
5. Catalano PM, Presley L, Minium J, et al. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 2009 32 6 1076-80.
6. Catalano PM, Ehrenberg HM. The shorte and longeterm implications of maternal obesity on the mother and her offspring. BJOG 2006 113 10 1126-33.
7. Rieck S, Kaestner KH. Expansion of betaecell mass in response to pregnancy. Trends Endocrinol Metab 2010;21(3):151-8.
8. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 1998;21(Suppl. 2):B19-26.
9. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) study: associations with maternal body mass index. BJOG 2010 117 5 575-84.
10. Catalano PM, McIntyre HD, Cruickshank JK, et al. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 2012 35 4 780-6.
11. Steinberg GR. Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle 2007 6 8 888-94.
12. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006 83 2 461s-5s.
13. Arkan MC, Hevener AL, Greten FR, et al. IKKebeta links inflammation to obesityeinduced insulin resistance. Nat Med 2005 11 2 191-8.
14. Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008 29 3 274-81.
15. Saben J, Zhong Y, Gomeze Acevedo H, et al. Early growth response proteine1 mediates lipotoxicityeassociated placental inflammation: role in maternal obesity. Am J Physiol Endocrinol Metab 2013;305(1):E1-14.
16. Basu S, Haghiac M, Surace P, et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 2011 19 3 476-82.
17. Xu H, Schultzee Mosgau A, Agic A, et al. Regulated upon activation, normal T cell expressed and secreted (RANTES) and monocyte chemotactic protein 1 in follicular fluid accumulate differentially in patients with and without endomee triosis undergoing in vitro fertilization. Fertil Steril 2006 86 6 1616-20.
18. Reyna SM, Ghosh S, Tantiwong P, et al. Elevated tollelike receptor 4 expression and signaling in muscle from insuline resistant subjects. Diabetes 2008 57 10 2595-602.
19. Schaeffler A, Gross P, Buettner R, et al. Fatty acideinduced induction of Tollelike receptore4/nuclear factorekappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 2009 126 2 233-45.
20. Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesitye and dieteinduced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001 293 5535 1673-7.
21. Nguyen MT, Favelyukis S, Nguyen AK, et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Tollelike receptors 2 and 4 and JNKedependent pathways. J Biol Chem 2007 282 48 35279-92.
22. Malti N, Merzouk H, Merzouk SA, et al. Oxidative stress and maternal obesity: fetoeplacental unit interaction. Placenta 2014 35 6 411-6.
23. Zera CA, Seely EW, Wilkinse Haug LE, et al. The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies. Am J Obstet Gynecol 2014 211 3 247.
24. Lappas M. Markers of endothelial cell dysfunction are increased in human omental adipose tissue from women with preeexisting maternal obesity and gestational diabetes. Metabolism 2014 63 6 860-73.
25. Saben J, Lindsey F, Zhong Y, et al. Maternal obesity is associated with a lipotoxic placental environment. Placenta 2014 35 3 171-7.
26. Higgins L, Mills TA, Greenwood SL, et al. Maternal obesity and its effect on placental cell turnover. J Matern Fetal Neonatal Med 2013 26 8 783-8.
27. Du M, Zhao JX, Yan X, et al. Fetal muscle development, mesenchymal multipotent cell differentiation, and associated signaling pathways. J Anim Sci 2011 89 2 583-90.
28. Athukorala C, Rumbold AR, Willson KJ, et al. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy and Childbirth 2010 10 56.
29. Gardosi J, Madurasinghe V, Williams M, et al. Maternal and fetal risk factors for stillbirth: population based study. BMJ 2013;346:f108.
30. Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med 2011 29 6 507-13.
31. Ovesen P, Rasmussen S, Kesmodel U. Effect of prepregnancy maternal overweight and obesity on pregnancy outcome. Obstet Gynecol 2011;118(2 Pt 1):305-12.
32. Doherty DA, Magann EF, Francis J, et al. Preepregnancy body mass index and pregnancy outcomes. Int J Gynaecol Obstet 2006 95 3 242-7.
33. Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287, 213 pregnancies in London. Int J Obes Relat Metab Disord 2001 25 8 1175-82.
34. Cedergren M. Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int J Gynaecol Obstet 2006 93 3 269-74.
35. Linne Y, Dye L, Barkeling B, et al. Weight development over time in parous women - the SPAWN study - 15 years followeup. Int J Obes Relat Metab Disord 2003 27 12 1516-22.
36. Kristensen J, Vestergaard M, Wisborg K, et al. Preepregnancy weight and the risk of stillbirth and neonatal death. BJOG 2005 112 4 403-8.
37. Chu SY, Kim SY, Lau J, et al. Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol 2007;197(3):223-8.
38. Aune D, Saugstad OD, Henriksen T, et al. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and metaeanalysis. JAMA 2014 311 15 1536-46.
39. Malee MP, Verma A, Messerlian G, et al. Association between maternal and child leptin levels 9 years after pregnancy complicated by gestational diabetes. Horm Metab Res 2002 34 4 212-6.
40. Morino K, Petersen KF, Dufour S, et al. Reduced mitochondrial density and increased IRSe1 serine phosphorylation in muscle of insulineresistant offspring of type 2 diabetic parents. J Clin Invest 2005 115 12 3587-93.
41. Barker DJ. Fetal programming of coronary heart disease. TTrends Endocrinol Metab 2002 13 9 364-8.
42. Krakowiak P, Walker CK, Bremer AA, et al. Maternal metabolic conditions and risk for autism and other neuroe developmental disorders. Pediatrics 2012;129(5):e1121-8.
43. Tanne JH. Maternal obesity and diabetes are linked to children's autism and similar disorders. BMJ 2012;344:e2768.
44. Samuelse Kalow ME, Funai EF, Buhimschi C, et al. Prepregnancy body mass index, hypertensive disorders of pregnancy, and longeterm maternal mortality. Am J Obstet Gynecol 2007;197(5). 490.e1-6.
45. Gluckman PD, Hanson MA, Pinal C. The developmental origins of adult disease. Matern Child Nutr 2005 1 3 130-41.
46. Rasmussen SA, Chu SY, Kim SY, et al. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol 2008 198 6 611-9.
47. Radulescu L, Munteanu O, Popa F, et al. The implications and consequences of maternal obesity on fetal intrauterine growth restriction. J Med Life 2013 6 3 292-8.
48. Ananth CV, Joseph KS, Oyelese Y, et al. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet Gynecol 2005;105(5 Pt 1):1084-91.
49. Alberico S, Montico M, Barresi V, et al. The role of gestational diabetes, preepregnancy body mass index and gestae tional weight gain on the risk of newborn macrosomia: results from a prospective multicentre study. BMC Pregnancy and Childbirth 2014 14 23.
50. McClure CK, Catov JM, Ness R, et al. Associations between gestational weight gain and BMI, abdominal adiposity, and traditional measures of cardiometabolic risk in mothers 8 y postpartum. Am J Clin Nutr 2013 98 5 1218-25.
51. Scholl TO, Hediger ML, Schall JI, et al. Gestational weight gain, pregnancy outcome, and postpartum weight retention. Obstet Gynecol 1995 86 3 423-7.
52. Gunderson EP, Abrams B, Selvin S. The relative importance of gestational gain and maternal characteristics associated with the risk of becoming overweight after pregnancy. Int J Obes Relat Metab Disord 2000 24 12 1660-8.
53. Bianco AT, Smilen SW, Davis Y, et al. Pregnancy outcome and weight gain recommendations for the morbidly obese woman. Obstet Gynecol 1998 91 1 97-102.
54. Knopp RH, Magee MS, Raisys V, et al. Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes 1991;40(Suppl. 2):165-71.
55. Sheard NF, Clark NG, Brande Miller JC, et al. Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the american diabetes association. Diabetes Care 2004 27 9 2266-71.
56. Scott C, Andersen CT, Valdez N, et al. No global consensus: a crossesectional survey of maternal weight policies. BMC Pregnancy and Childbirth 2014 14 167.
57. Milani S, Bossi A, Bertino E, et al. Differences in size at birth are determined by differences in growth velocity during early prenatal life. Pediatr Res 2005 57 2 205-10.
58. Mooke Kanamori DO, Durmus B, Sovio U, et al. Fetal and infant growth and the risk of obesity during early childhood: the Generation R Study. Eur J Endocrinol 2011 165 4 623-30.
59. Tzoulaki I, Sovio U, Pillas D, et al. Relation of immediate postnatal growth with obesity and related metabolic risk factors in adulthood: the northern Finland birth cohort 1966 study. Am J Epidemiol 2010 171 9 989-98.
60. Ong KK, Preece MA, Emmett PM, et al. Size at birth and early childhood growth in relation to maternal smoking, parity and infant breastefeeding: longitudinal birth cohort study and analysis. Pediatr Res 2002 52 6 863-7.
61. Cogswell ME, Scanlon KS, Fein SB, et al. Medically advised, mother's personal target, and actual weight gain during pregnancy. Obstet Gynecol 1999 94 4 616-22.
62. ACOG Committee opinion no. 549: obesity in pregnancy. Obstet Gynecol 2013 121 1 213-7.
63. Stothard KJ, Tennant PW, Bell R, et al. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and metaeanalysis. JAMA 2009 301 6 636-50.
64. Bodnar LM, Catov JM, Klebanoff MA, et al. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 2007 18 2 234-9.
65. Renault KM, Norgaard K, Nilas L, et al. The Treatment of Obese Pregnant Women (TOP) study: a randomized controlled trial of the effect of physical activity intervention assessed by pedometer with or without dietary intervention in obese pregnant women. Am J Obstet Gynecol 2014;210(2). 134.e1-9.
66. Guelinckx I, Devlieger R, Vansant G. Pregnancies complicated by obesity: clinical approach and nutritional management. Verh K Acad Geneeskd Belg 2010;72(5-6):253-76.
67. Polley BA, Wing RR, Sims CJ. Randomized controlled trial to prevent excessive weight gain in pregnant women. Int J Obes Relat Metab Disord 2002 26 11 1494-502.
68. Streuling I, Beyerlein A, Rosenfeld E, et al. Physical activity and gestational weight gain: a metaeanalysis of intervention trials. BJOG 2011 118 3 278-84.
69. Skouteris H, Hartleye Clark L, McCabe M, et al. Preventing excessive gestational weight gain: a systematic review of interventions. Obes Rev 2010 11 11 757-68.
70. Connor Gorber S, Tremblay M, Moher D, et al. A comparison of direct vs. selfereport measures for assessing height, weight and body mass index: a systematic review. Obes Rev 2007 8 4 307-26.
71. National Collaborating Centre for Ws, Children's H. National Institute for Health and Clinical Excellence: guidance. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. London: RCOG Press. National Collaborating Centre for Women's and Children's Health; 2008.
72. Maxwell MH, Waks AU, Schroth PC, et al. Error in bloodepressure measurement due to incorrect cuff size in obese patients. Lancet 1982 2 8288 33-6.
73. Hildebrand E, Kallen B, Josefsson A, et al. Maternal obesity and risk of Down syndrome in the offspring. Prenat Diagn 2014 34 4 310-5.
74. Davies GA, Maxwell C, McLeod L, et al. Obesity in pregnancy. J Obstet Gynaecol Can 2010 32 2 165-73.
75. Chung JT, Son WY, Zhang XY, et al. Normal birth following PGD for reciprocal translocation after serial vitrification of oocytes from a poor responder: a case report. Reproductive Biomedicine Online 2012 25 5 521-6.
76. Best KE, Tennant PW, Bell R, et al. Impact of maternal body mass index on the antenatal detection of congenital anomalies. BJOG 2012 119 12 1503-11.
77. Harper LM, Jauk VC, Owen J, et al. The utility of ultrasound surveillance of fluid and growth in obese women. Am J Obstet Gynecol 2014.
78. Gupta M, Lauring J, Kunselman AR, et al. Fetal growth restriction may be underestimated in obese patients. Obstet Gynecol 2014;123(Suppl. 1):98s-9s.
79. Mintz MC, Landon MB. vaSonographic diagnosis of fetal growth disorders. Clin Obstet Gynecol 1988 31 1 44-52.
80. Hibbard JU, Gilbert S, Landon MB, et al. Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. Obstet Gynecol 2006 108 1 125-33.
81. Morgan ES, Wilson E, Watkins T, et al. Maternal obesity and venous thromboembolism. Int J Obstet Anesth 2012;21(3):253-63.
82. Isoda K, Young JL, Zirlik A, et al. Metformin inhibits proinflammatory responses and nuclear factorekappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol 2006 26 3 611-7.
83. Dandona P, Aljada A, Ghanim H, et al. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 2004 89 10 5043-7.
84. Fleming R, Hopkinson ZE, Wallace AM, et al. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placeboecontrolled trial. J Clin Endocrinol Metab 2002;87(2):569-74.
85. Tang T, Glanville J, Hayden CJ, et al. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placeboecontrolled, doubleeblind multicentre study. Hum Reprod 2006 21 1 80-9.
86. Su DF, Wang XY. Metformin vs insulin in the management of gestational diabetes: a systematic review and metae analysis. Diabetes Res Clin Pract 2014 104 3 353-7.
87. Lautatzis ME, Goulis DG, Vrontakis M. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. Metabolism 2013 62 11 1522-34.
88. Nicholson W, Baptistee Roberts K. Oral hypoglycaemic agents during pregnancy: the evidence for effectiveness and safety. Best Pract Res Clin Obstet Gynaecol 2011 25 1 51-63.
89. Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008 358 19 2003-15.
90. Elliott BD, Langer O, Schuessling F. Human placental glucose uptake and transport are not altered by the oral antie hyperglycemic agent metformin. Am J Obstet Gynecol 1997 176 3 527-30.
91. Ghazeeri GS, Nassar AH, Younes Z, et al. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview. Acta Obstet Gynecol Scand 2012 91 6 658-78.
92. Khattab S, Mohsen IA, Aboul Foutouh I, et al. Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecol Endocrinol 2011;27(10):789-93.
93. Fougner KJ, Vanky E, Carlsen SM. Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized doubleeblind study. Scand J Clin Lab Invest 2008 68 8 771-6.
94. Glueck CJ, Goldenberg N, Wang P, et al. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 2004 19 3 510-21.
95. Coustan DR. Diagnosis of gestational diabetes. Scand J Clin Lab Invest Suppl 2014 74 244 27-33.
96. Duran A, Saenz S, Torrejon MJ, et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study. Diabetes Care 2014 37 9 2442-50.
97. Whitaker RC. Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics 2004;114(1):e29-36.
98. Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115(3):e290-6.
99. Salomaki H, Vahatalo LH, Laurila K, et al. Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood. PLoS One 2013;8(2):e56594.
100. Ray JG, Wyatt PR, Vermeulen MJ, et al. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol 2005 105 2 261-5.
101. Weiss JL, Malone FD, Emig D, et al. Obesity, obstetric complications and cesarean delivery rate e a populationebased screening study. Am J Obstet Gynecol 2004 190 4 1091-7.
102. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358(19):1991-2002.
103. Crane JM, Murphy P, Burrage L, et al. Maternal and perinatal outcomes of extreme obesity in pregnancy. J Obstet Gynaecol Can 2013 35 7 606-11.
104. Jensen TB, Gerds TA, Gron R, et al. Risk factors for venous thromboembolism during pregnancy. Pharmacoepidemiol Drug Saf 2013 22 12 1283-91.
105. Knight M. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG 2008 115 4 453-61.
106. Larsen TB, Sorensen HT, Gislum M, et al. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a populationebased nested caseecontrol study. Thromb Res 2007 120 4 505-9.
107. Fyfe EM, Thompson JM, Anderson NH, et al. Maternal obesity and postpartum haemorrhage after vaginal and caesarean delivery among nulliparous women at term: a retrospective cohort study. BMC Pregnancy and Childbirth 2012 12 112.
108. Bautistae Castano I, Henriqueze Sanchez P, Alemane Perez N, et al. Maternal obesity in early pregnancy and risk of adverse outcomes. PLoS One 2013;8(11):e80410.
109. Durnwald CP, Ehrenberg HM, Mercer BM. The impact of maternal obesity and weight gain on vaginal birth after cesarean section success. Am J Obstet Gynecol 2004 191 3 954-7.
110. Stamilio DM, Scifres CM. Extreme obesity and postcesarean maternal complications. Obstet Gynecol 2014;124(2 Pt 1):227-32.
111. Sekhavat L, Fallah R. Could maternal preepregnancy body mass index affect Apgar score? Arch Gynecol Obstet 2013 287 1 15-8.
112. Meehan S, Beck CR, Maire Jenkins J, et al. Maternal obesity and infant mortality: a metaeanalysis. Pediatrics 2014 133 5 863-71.
113. Cantwell R, Cluttone Brock T, Cooper G, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG 2011;118(Suppl. 1):1-203.
114. Curhan GC, Chertow GM, Willett WC, et al. Birth weight and adult hypertension and obesity in women. Circulation 1996 94 6 1310-5.